BioSpace News Archive

Workplace Apologies 101: How to Say “I’m Sorry” to Colleagues, Your Boss

Everyone makes mistakes, which means knowing how to apologize is an essential part of building strong, productive relationships in your personal life and at work.

March 27, 2019
·
4 min read
·
Editorial Staff
Drug Development

Artificial Womb Technology Benefits Animal Subjects. Could It Work in Humans?

The artificial womb technology was able to maintain extremely preterm lamb fetuses, which were equivalent to a human fetus at 24 weeks of gestation.

March 27, 2019
·
2 min read
·
Alex Keown
Deals

March Madness: “The Fabulous 5" Life Science IPOs

March has been a busy month for biopharma and medical device company initial public offerings. Here’s a look at the top IPO stories for the month.

March 27, 2019
·
3 min read
·
Mark Terry
Drug Development

“Golden Girls” Mice Are Key to Longevity Research

Grace and Blanche, who were second cousins, for a time were believed to be the oldest living mice in the world prior to their death.

March 27, 2019
·
4 min read
·
Mark Terry
Policy

2 Potential Blockbusters: AbbVie’s Pipeline Looks Promising

On March 26, AbbVie announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) approved its Skyrizi (risankizumab) for plaque psoriasis, generalized pustular psoriasis, erythrodermic psoriasis and psoriatic arthritis in adults who haven’t responded to conventional therapies.

March 27, 2019
·
4 min read
·
Mark Terry
Business

Exclusive: Platelet Biogenesis Eyes Entering the Clinic, Doubling Employment This Year

The polar vortex that brought bone-chilling temperatures to much of the United States earlier this winter highlighted a near constant concern – an inadequate supply of platelets at blood centers across the country.

March 27, 2019
·
3 min read
·
Alex Keown
Deals

NASH and an $135 Million IPO: An Interview With Genfit’s Dean Hum

Genfit, with offices in Lille, France and Cambridge, Mass., launched its initial public offering (IPO) on the Nasdaq on March 27. Dean Hum, chief operating officer of Genfit, took time out to speak with BioSpace about the company, the IPO and elafibranor.

March 27, 2019
·
4 min read
·
Mark Terry
FDA

Novartis Wins Fast-Track Approval for Multiple Sclerosis Drug Mayzent

Novartis will quickly roll Mayzent out to U.S. physicians. The Swiss pharma giant plans to make the drug available within one week of the FDA approval.

March 27, 2019
·
3 min read
·
Alex Keown
Business

Lilly and ImmuNext Ink $605 Million+ Autoimmune Research Pact

The two companies will work on a preclinical target in hopes of finding new therapies for autoimmune diseases that regulate immune cell metabolism.

March 27, 2019
·
2 min read
·
Mark Terry
Business

Alexion Salaries Jumped in 2018 Following Move to Boston

The median salaries for Alexion employees increased to nearly $224,000 in 2018. The previous year the median salary was $167,000.

March 27, 2019
·
2 min read
·
Alex Keown